• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过随机起始/双侧卵巢刺激来最大化早期乳腺癌患者生育力保存的安全性和有效性。

Maximize the safety and efficacy of fertility preservation by random start/dual ovarian stimulation for early breast cancer patients.

作者信息

Young Shih-Hung Richard, Chang Yi-En, Yang Wei-Chung Vivian, Lu Buo-Jia, Chou Szu-Yuan, Chen Chi-Huang

机构信息

Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Obstetrics and Gynecology, Hung-Chi Women & Children's Hospital, Taoyuan, Taiwan.

Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan.

出版信息

Taiwan J Obstet Gynecol. 2023 Mar;62(2):330-333. doi: 10.1016/j.tjog.2022.08.017.

DOI:10.1016/j.tjog.2022.08.017
PMID:36965903
Abstract

OBJECTIVE

What is the more efficient and safer protocol during controlled ovarian hyperstimulation (COH) for early-stage breast cancer patients seeking emergency fertility preservation before adjuvant chemo/radiotherapy?

MATERIALS AND METHODS

This retrospective, case-series study involved two early-stage (Ia) breast cancer patients that requested for fertility preservation within 3 weeks. Random start/dual stimulation protocols with aromatase inhibitor (AI) were used to maximize oocyte yield and suppress serum estradiol (E2) level.

RESULTS

E2 levels on trigger day during dual COH were between 112.0 and 407.0 pg/mL. Duration of COH could be shortened to only 17 days, and up to 41 oocytes were successfully retrieved with two retrievals.

CONCLUSION

This remarkable efficient and safe protocol involves the combination of random start/dual stimulation with step-up AI dosage beforehand which not only maximize oocyte yield within the shortest possible timeframe, but also to maintain the low level of E2 to avoid over-stimulating estrogen-sensitive cancer cells and to decrease the risk of developing ovarian hyperstimulation syndrome (OHSS).

摘要

目的

对于在辅助化疗/放疗前寻求紧急生育力保存的早期乳腺癌患者,在控制性卵巢过度刺激(COH)期间,哪种方案更高效且更安全?

材料与方法

这项回顾性病例系列研究纳入了两名在3周内要求保留生育力的早期(Ia期)乳腺癌患者。采用随机起始/双重刺激方案联合芳香化酶抑制剂(AI),以最大化卵母细胞产量并抑制血清雌二醇(E2)水平。

结果

双重COH期间扳机日的E2水平在112.0至407.0 pg/mL之间。COH的持续时间可缩短至仅17天,通过两次取卵成功获取了多达41个卵母细胞。

结论

这种显著高效且安全的方案包括随机起始/双重刺激与预先逐步增加AI剂量的组合,这不仅能在最短时间内最大化卵母细胞产量,还能维持E2的低水平,以避免过度刺激雌激素敏感的癌细胞,并降低发生卵巢过度刺激综合征(OHSS)的风险。

相似文献

1
Maximize the safety and efficacy of fertility preservation by random start/dual ovarian stimulation for early breast cancer patients.通过随机起始/双侧卵巢刺激来最大化早期乳腺癌患者生育力保存的安全性和有效性。
Taiwan J Obstet Gynecol. 2023 Mar;62(2):330-333. doi: 10.1016/j.tjog.2022.08.017.
2
The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.早期乳腺癌女性生育力保存中控制性卵巢过度刺激的安全性和有效性:一项系统评价
Hum Reprod. 2017 May 1;32(5):1033-1045. doi: 10.1093/humrep/dex027.
3
Two cases of polycystic ovary syndrome with onset of severe ovarian hyperstimulation syndrome following controlled ovarian stimulation with aromatase inhibitors for fertility preservation before breast cancer treatment.两例多囊卵巢综合征患者,在乳腺癌治疗前进行生育力保存的控制性卵巢刺激中使用芳香化酶抑制剂后出现严重卵巢过度刺激综合征。
Taiwan J Obstet Gynecol. 2021 Sep;60(5):931-934. doi: 10.1016/j.tjog.2021.07.028.
4
Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.来曲唑随机起始控制性卵巢刺激用于癌症患者生育力保存:病例系列及文献综述
J Pak Med Assoc. 2014 Jul;64(7):830-2.
5
Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.在乳腺癌患者体外受精的控制性卵巢刺激过程中联合使用他莫昔芬可提高生育力保留治疗策略的安全性。
Fertil Steril. 2014 Aug;102(2):488-495.e3. doi: 10.1016/j.fertnstert.2014.05.017. Epub 2014 Jun 14.
6
Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.癌症患者生育力保存中随机启动与控制性卵巢刺激周期的卵母细胞和胚胎质量比较
Reprod Sci. 2021 Aug;28(8):2200-2207. doi: 10.1007/s43032-020-00412-2. Epub 2021 Jan 6.
7
The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.芳香化酶抑制剂对青少年及年轻癌症患者卵母细胞冷冻保存的控制性卵巢刺激的影响。
J Obstet Gynaecol Res. 2023 Mar;49(3):973-979. doi: 10.1111/jog.15535. Epub 2023 Jan 6.
8
Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.随机启动卵巢刺激用于在性腺毒性癌症治疗前希望保留生育能力的女性的卵母细胞或胚胎冷冻保存。
Curr Pharm Biotechnol. 2017 Nov 10;18(8):609-613. doi: 10.2174/1389201018666170808122531.
9
COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.乳腺癌患者生育力保存的控制性卵巢刺激结果:与按年龄预期反应的比较。
J Assist Reprod Genet. 2020 Dec;37(12):3069-3076. doi: 10.1007/s10815-020-01944-x. Epub 2020 Sep 18.
10
Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers.来曲唑相关控制性卵巢刺激在乳腺癌患者与不孕患者常规控制性卵巢刺激中的应用:卵母细胞质量相关生物标志物的评估。
Reprod Biol Endocrinol. 2019 Jan 3;17(1):3. doi: 10.1186/s12958-018-0443-x.